Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II study
Phase 1
- Conditions
- T3(UICC)-pancreatic cancer
- Registration Number
- JPRN-UMIN000004422
- Lead Sponsor
- Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Liver, renal dysfunction, severe coronary disease. Unresectable pancreatic cancer, including borderline resectable cases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Disease free survival
- Secondary Outcome Measures
Name Time Method Overall survival, Histopathological and immunological response, pattern of recurrence